Brain Nitric Oxide Changes After Controlled Cortical Impact Injury in Rats
Overview
Physiology
Authors
Affiliations
Nitric oxide (NO) and the NO end products, nitrate and nitrite, were measured at the impact site after a 5-m/s, 3-mm deformation controlled cortical impact injury in rats. Immediately after the impact injury and the NO and microdialysis probes could be replaced, there was an increase from baseline in NO concentration of 83 +/- 16 (SE) nM, compared with 0.5 +/- 4 nM in the sham injured animals (P < 0.001). This marked increase in NO occurred at the time of the initial rise in blood pressure (BP) and intracranial pressure (ICP) in response to the injury. After the initial increase in BP and ICP, the BP decreased and stabilized at a value which was approximately 20 mmHg below the preinjury values, and ICP plateaued at an average value of 20 mmHg, compared with 8 mmHg in the sham-injured animals. This provided an average cerebral perfusion pressure of 40-50 mmHg, compared with 65-75 mmHg for the sham-injured animals. These values were relatively constant for the remainder of the 3-h monitoring period. The NO values also stabilized during this time period. By 1 h after the impact injury the NO concentration measured directly using the NO electrode had decreased from baseline values by an average value of 25 +/- 6 nM. NO concentration remained significantly lower than baseline values throughout the remainder of the 3-h monitoring period. The concentration of nitrate/nitrite in the dialysate fluid also decreased by an average value of 341 +/- 283 nM 20-40 min after the injury. Dialysate nitrite/nitrate concentrations remained less than the preinjury baseline values throughout the remainder of the 3-h monitoring period. Preinjury treatment with L-nitro-arginine methyl ester (L-NAME) blunted the injury-induced increase in NO and resulted in more severe immediate intracranial hypertension and more severe systemic hypotension at one hour after injury. Mortality was also 67% with L-NAME pretreatment, compared with 1% in untreated animals.
Effect of Bevacizumab on traumatic penumbra brain edema in rats at different time points.
Ai L, Xin C, Usman M, Zhu Y, Lu H Tissue Barriers. 2023; 12(4):2292463.
PMID: 38084736 PMC: 11583617. DOI: 10.1080/21688370.2023.2292463.
Jones T, Mackey T, Juba A, Amin K, Atyam A, McDole M Exp Neurol. 2023; 372:114621.
PMID: 38029809 PMC: 10872660. DOI: 10.1016/j.expneurol.2023.114621.
Smith C, Carpenter K, Hutchinson P, Smielewski P, Helmy A J Cereb Blood Flow Metab. 2023; 43(8):1237-1253.
PMID: 37132274 PMC: 10369156. DOI: 10.1177/0271678X231171991.
Lenz I, Plesnila N, Terpolilli N J Cereb Blood Flow Metab. 2020; 41(7):1669-1681.
PMID: 33256507 PMC: 8221759. DOI: 10.1177/0271678X20973787.
Antioxidant Therapies in Traumatic Brain Injury.
Di Pietro V, Yakoub K, Caruso G, Lazzarino G, Signoretti S, Barbey A Antioxidants (Basel). 2020; 9(3).
PMID: 32235799 PMC: 7139349. DOI: 10.3390/antiox9030260.